Transpact Enterprises Private Limited, a Social Enterprise launched in the year 2013 , incubated at SINE-IIT Bombay & accelerated under CIIE IIM Ahmedabad. It is starts up to design, development, manufacturing, and distribution of therapeutic devices and rehabilitations services.
The aim of Transpact is to produce significantly needed Medico-products which are the necessity for betterment of Human Society. Ultimately allowing people to TRANScend their barriers and thus, create a positive imPACT on their lives.
Our Vision is to impact lives of people through continuous technological interventions and innovations by providing innovative, cost-effective and comprehensive solutions, products and services with strategic partnerships and collaborative relationships to help specially abled people to transcend their barriers.
We are located at SINE, CSIR Building , IIT-Bombay Campus, Powai Mumbai and having head office at 204, Timmy Arcade, Makwana Road Marole Andheri Mumbai, India . We have successfully accomplished the ISO 13485:2016 certification for medical devices. Our pursuit for the excellent quality is reflected in the ISO 9001:2015 certification for quality management system.
2. 22
Agenda
1. Overview
2. Product Info and Details
3. The Problem
4. Current Solution
5. Opportunity
6. Vestibulator™ Product
7. Team
8. Our Strategy
9. Financial Viability
10. Break Even Analysis
11. Investors IRR/ROI
12. Why Us?
13. Roadmap
14. Fund Requirement
15. Awards/Certifications
3. 33
Overview
Transpact® is a Social Enterprise in Joint research with Industrial
Research Center of IIT Bombay to commercialize innovative and
patented therapeutic device, incubated at SINE (Society for Innovation and
Entrepreneurship), IIT Bombay and CIIE (Center for Innovation
Incubation and Entrepreneurship) IIM Ahmedabad
Vision: To impact lives of people through
continuous technological interventions and
innovations.
Mission: To provide innovative, cost-effective
and comprehensive solutions, products and
services with strategic partnerships and
collaborative relationships to help specially
abled people to transcend their barriers.
4. 170 million children in the world with developmental
disabilities, 14 million in India1
CP & Autism count for 20% of all disabilities2
40% of adults above 40 years have some sort Vestibular
dysfunctions leading to dizziness & balance issues.
Shortage of qualified Physiotherapists and Occupation
therapists (1 in 10,000 Population/Only 50000 in India –
WHO)
44
The Problem
Source of Data
1-Source: AYU .34(1); Jan-Mar 2013 2- CDC-2012
6. 66
Opportunity
Market Size
The demand for physiotherapy and rehabilitation equipment
currently represents a global market share of approximately $6 billion
Outpatient rehabilitation is $29.6 billion industry that is expected to grow
7% annually through.
Target Segment
Cerebral Palsy and Autism Children
Vertigo, Accidental strains, Paralysis attack, Post-Surgery rehabilitation
and sports injury.
Estimated Number of Buyers (India)
All Hospitals having physiotherapy department – 2,35,000 Hospitals
Special Children Schools – 2,500
Physiotherapy Centers – 70,000
Individuals with CP/Autism (Future version)
7. 77
Vestibulator™- Product Info
A scientific therapeutic device to stimulate
Vestibular system of Cerebral Palsy children.
Introducing first time ever prescription in
Physiotherapy
5X improvement, multiple kids handling
simultaneously and consistency in treatment.
An instrument for Vestibular checking and
testing.
Motorized as well as Manual version to serve
the need of rural sector.
8. 88
Product Details
Vestibulator™ Vestibular + Stimulator
“Pacemaker” for Vestibular System (Internal GPS system for the body)
Positioning
Supine
Prone
Sitting
Quadruped
kneeling
standing
Stimulation
Forward
Backward
Tilting
Linear
Gravitational
9. 99
Product Journey
Year 2013
Academic Research
Need Identification
SRCC Project
Year 2014
Proof of Concept
SAARTHI School
Year 2015
Functional Prototype - Alpha
Patent Filed
Year 2016
Beta Version
Clinical Trial/Study
10. 1010
Current Status - 2017
Year 2017
RTM (Release To Market) Version
Top 10 Customers – Initial discussions with 3 Hospitals in Mumbai
11. 1111
Aaliya Baig
Program Manager responsible for business processes, operation and
regulatory compliances along with co-ordination on product development .
MBA in HR and MSc from Mumbai University.
Kamlesh Sawant
Over 10 years of experience in the areas of Engineering, Consulting, Research
and Development
Worked on product design projects in Healthcare and Pharma segment
M.Des Industrial Design from IDC IIT Bombay and B.E. Mechanical
Engineering
Sanjay Bobade
A Production Engineer with over 13 years of work experience in design and
fabrication of SPM (special purpose machines), conveyors, Machine tools
Rajesh Shipurkar
Over 20 years of experience in Fabrication, Tool and die making
Product Team
12. 1212
Founding Team
Aslam Khan
A serial entrepreneur in Information Technology and Healthcare industry with
20 years experience.
Proven track-record in starting up and growing businesses in global market.
Engineering graduate with management qualification from IIM Calcutta and
Business education from Harvard Business School, MIT’s Sloan School of
Management, and Said Business School of Oxford University.
Anis Choudhary
A passionate social worker, entrepreneur and management guru
22 years experience in administration, operation and academics.
MSc, MBA, Mphil from Mumbai University.
Sudhir Bania
18 years of rich experience in creative and functional product design.
Delivered award winning designs for F500 clients - Samsung, GE, Reliance
Master of Design from IIT Bombay. Associated with NID Ahmedabad, MIT ID
Pune and IIMA.
13. 1313
Board of Advisors
Prof GG Ray
Head of IDC-IIT Bombay. Senior Scientist in field of Ergonomics for 40 years.
President of Indian Society of Ergonomics and Chairman of Bureau of Indian
Standards, Ergonomics section.
Dr Dhruve Mehta
Experienced Physiotherapist wit 35 years of experience specializing in
Cerebral Palsy.
Recipient of Dr. PN Berry’s scholarship for United Kingdom.
Ms Lavanya Buchwal
Research Associate and a child nutrition specialist associated with Apollo
polyclinic
Dr Nikhil Bhandari
Consulting Pediatrician & Neonatologist and a certified PAL from American
Academy of Pediatrics
14. 1414
Our Strategy
International Patent of Vestibulator™
Vestibulator™ built to meet consumer and business need
Vestibulator™ Standard – Motorized version for Center/Hospital
Vestibulator™ Professional – For corporate Use
Vestibulator™ Light – For Home Use
Vestibulator™ Easy – Manually operated for Rural sector
Pricing Model - Outright, Rent, Pay-per-Use
Integrated Software for patient data analytics
An echo system with Corporate-NGO partnership under CSR
Continue research and product enhancement by IRCC of IIT
Bombay
Certification by CLAA/CE (India), MHRA (UK) and FDA (USA)
Manufacturing by ISO 13485 certified company
Approval of Ministry of Social Justice, IAPA
15. 1515
Financial Viability
Primarily there are 3 revenue streams
1. Product Sales
Vestibulator™ Standard – $11,500/-
Vestibulator™ Professional – $15,000/-
1. Annual Maintenance Contract
2. Upgrade from Vestibulator™ 1.0 to 2.0 – Additional revenue
3. Accessories Sale, Training and Services
We expect the project to breakeven in 3rd
Year and stable rise
in the business and revenue from that point.
Initial 1 year will be entirely invested in Packaging, Marketing,
Business Development and Channel Partnership
16. 1616
Pricing Viability for Customer
850000
170000
680000
48
17907
0.12
VESTIBULATOR® COST
PERSONAL CONTRIBUTION
LOAN ASKED
PERIOD IN MONTHS
P.A + INST/ MONTH
INT.ON LOAN AMOUNT
OUTGOING (X) 1ST YEAR 2ND YEAR 3RD YEAR 4TH YEAR
EMI ON LOAN VALUE 17907 17907 17907 17907
ELECTRICITY /MONTH 1260 1620 2760 3360
CONSUMABLE/MONTH 5040 6480 10350 15120
DEPRECIATION/MONTH 17708 17708 17708 17708
MAINTENANCE/REPAIR 7083 7083 7083 7083
SALARY/MONTH 96000 139500 179250 247500
TOTAL EXPENSE/MONTH 144999 190299 235059 308679
INCOMING (Y)
PHYSIO PATIENT/DAY 10 12 15 18
PATIENT/MONTH (30 days) 300 360 450 540
FEES/PATIENT 400 450 450 500
INCOME/M A 120000 162000 202500 270000
CP PATIENT/DAY 4 6 8 10
PATIENT/MONTH (30 days) 120 180 240 300
FEES/PATIENT 600 650 650 750
INCOME/M B 72000 117000 156000 225000
TOTAL INC A+B 192000 279000 358500 495000
PROFIT/M(X-Y) 47001 88701 123441 186321
PROFIT / YEAR 564016 1064416 1481296 2235856
* Figures in INR
* Cost Rs. 8,50,000 = $ 11,500
17. 1717
Project Break Even
The estimated unit cost of manufacturing the Vestibulator™ $4,000 and average sales cost of
unit is considered as $11,500.
Number of units planned to be manufactured in Year 6 is 2000.
Administrative expense includes salaries of personnel and travelling expenses.
** Figures in USD
Particulars Year 1 Year 2 Year 3 Year 4 Year 5
Vestibulator™ Unit Sales 0 100 500 1000 2000
Income (Sales Revenue) 0 1,150,000 5,750,000 11,500,000 23,000,000
Cost of Sales 400,000 2,000,000 4,000,000 8,000,000 8,000,000
Gross Margin -400,000 -850,000 1,750,000 3,500,000 15,000,000
Administrative Expenses 200,000 300,000 400,000 400,000 400,000
Sales/Marketing Expenses 400,000 400,000 400,000 600,000 1,000,000
Research & Development 0 200,000 200,000 300,000 500,000
Total Operating Expenses 600,000 900,000 1,000,000 1,300,000 1,900,000
Net Profit -1,000,000 -1,750,000 750,000 2,200,000 13,100,000
18. 1818
Returns on Investment
• The revenue stream to investor is as stated above
• The project will generate positive cash flow from year 3
• The project IRR in our structure for investor stands at 12.5% for investment of $3 (2.75) million for 5
years
Particulars Year 1 Year 2 Year 3 Year 4 Year 5
Net Profit -1,000,000 -1,750,000 750,000 2,200,000 13,100,000
Returns to Investors (30%) 0 0 225,000 660,000 3,930,000
Total Returns (cummulative) 0 0 225,000 885,000 4,815,000
Initial Investment (2,750,000)
Returns in Year 1 0
Returns in Year 2 0
Returns in Year 3 225,000
Returns in Year 4 660,000
Returns in Year 5 3,930,000
IRR 12.51%
19. 1919
Why Us?
Vestibulator™ is unique and innovative invention in therapeutics
instrument segment.
The device is easy and safe to use, durable and light weight for
portability.
Certification from authorized body for safety and quality.
Collaboration with “SAARTHI School for Special Children” for quality
assurance and testing of instrument.
Professional industrial design team with proven track record driving the
product.
Highly Experienced expert Physiotherapists, Ergonomics and Nutrition
researcher on board.
21. 2121
Financial Requirements
Currently Seeking $1,000,000 Capital
• Expected value of the Enterprise/Project is estimated at $8 Million pre-
money valuation
• Targeted Closing Date: 31st
August 2017
• $100,000: Beta, CE Certification and QA cost
• $400,000: Advance for manufacturing cost
• $300,000: Marketing and Biz Dev cost for analysis/globalization
• $100,000: Founders working full-time marketing/launching the product
• $100,000: Infrastructure, Legal, Compliance and Misc. expenses
Funds Utilization of SEED